MTOR and Unclassified Renal Cell Carcinoma: Of the MTOR mutations seen in this cohort (Fig. 3b), I1973F has been described and shown to be hyperactive in cell-based assays35, 36, whereas L2427R (recurred three times in our uRCC cohort) and V2475M mutations have not yet been reported.